Effects of pramipexole on the processing of rewarding and aversive taste stimuli.

RATIONALE: Pramipexole, a D2/D3 dopamine receptor agonist, has been implicated in the development of impulse control disorders in patients with Parkinson's disease. Investigation of single doses of pramipexole in healthy participants in reward-based learning tasks has shown inhibition of the ne...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Mccabe, C, Harwood, J, Brouwer, S, Harmer, C, Cowen, P
Format: Journal article
Sprog:English
Udgivet: 2013
_version_ 1826300345877266432
author Mccabe, C
Harwood, J
Brouwer, S
Harmer, C
Cowen, P
author_facet Mccabe, C
Harwood, J
Brouwer, S
Harmer, C
Cowen, P
author_sort Mccabe, C
collection OXFORD
description RATIONALE: Pramipexole, a D2/D3 dopamine receptor agonist, has been implicated in the development of impulse control disorders in patients with Parkinson's disease. Investigation of single doses of pramipexole in healthy participants in reward-based learning tasks has shown inhibition of the neural processing of reward, presumptively through stimulation of dopamine autoreceptors. OBJECTIVES: This study aims to examine the effects of pramipexole on the neural response to the passive receipt of rewarding and aversive sight and taste stimuli. METHODS: We used functional magnetic resonance imaging to examine the neural responses to the sight and taste of pleasant (chocolate) and aversive (mouldy strawberry) stimuli in 16 healthy volunteers who received a single dose of pramipexole (0.25 mg) and placebo in a double-blind, within-subject, design. RESULTS: Relative to placebo, pramipexole treatment reduced blood oxygen level-dependent activation to the chocolate stimuli in the areas known to play a key role in reward, including the ventromedial prefrontal cortex, the orbitofrontal cortex, striatum, thalamus and dorsal anterior cingulate cortex. Pramipexole also reduced activation to the aversive condition in the dorsal anterior cingulate cortex. There were no effects of pramipexole on the subjective ratings of the stimuli. CONCLUSIONS: Our results are consistent with an ability of acute, low-dose pramipexole to diminish dopamine-mediated responses to both rewarding and aversive taste stimuli, perhaps through an inhibitory action of D2/3 autoreceptors on phasic burst activity of midbrain dopamine neurones. The ability of pramipexole to inhibit aversive processing might potentiate its adverse behavioural effects and could also play a role in its proposed efficacy in treatment-resistant depression.
first_indexed 2024-03-07T05:15:44Z
format Journal article
id oxford-uuid:dd1dcda8-afc7-47ae-b3b1-e3a11a8e127e
institution University of Oxford
language English
last_indexed 2024-03-07T05:15:44Z
publishDate 2013
record_format dspace
spelling oxford-uuid:dd1dcda8-afc7-47ae-b3b1-e3a11a8e127e2022-03-27T09:22:43ZEffects of pramipexole on the processing of rewarding and aversive taste stimuli.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dd1dcda8-afc7-47ae-b3b1-e3a11a8e127eEnglishSymplectic Elements at Oxford2013Mccabe, CHarwood, JBrouwer, SHarmer, CCowen, PRATIONALE: Pramipexole, a D2/D3 dopamine receptor agonist, has been implicated in the development of impulse control disorders in patients with Parkinson's disease. Investigation of single doses of pramipexole in healthy participants in reward-based learning tasks has shown inhibition of the neural processing of reward, presumptively through stimulation of dopamine autoreceptors. OBJECTIVES: This study aims to examine the effects of pramipexole on the neural response to the passive receipt of rewarding and aversive sight and taste stimuli. METHODS: We used functional magnetic resonance imaging to examine the neural responses to the sight and taste of pleasant (chocolate) and aversive (mouldy strawberry) stimuli in 16 healthy volunteers who received a single dose of pramipexole (0.25 mg) and placebo in a double-blind, within-subject, design. RESULTS: Relative to placebo, pramipexole treatment reduced blood oxygen level-dependent activation to the chocolate stimuli in the areas known to play a key role in reward, including the ventromedial prefrontal cortex, the orbitofrontal cortex, striatum, thalamus and dorsal anterior cingulate cortex. Pramipexole also reduced activation to the aversive condition in the dorsal anterior cingulate cortex. There were no effects of pramipexole on the subjective ratings of the stimuli. CONCLUSIONS: Our results are consistent with an ability of acute, low-dose pramipexole to diminish dopamine-mediated responses to both rewarding and aversive taste stimuli, perhaps through an inhibitory action of D2/3 autoreceptors on phasic burst activity of midbrain dopamine neurones. The ability of pramipexole to inhibit aversive processing might potentiate its adverse behavioural effects and could also play a role in its proposed efficacy in treatment-resistant depression.
spellingShingle Mccabe, C
Harwood, J
Brouwer, S
Harmer, C
Cowen, P
Effects of pramipexole on the processing of rewarding and aversive taste stimuli.
title Effects of pramipexole on the processing of rewarding and aversive taste stimuli.
title_full Effects of pramipexole on the processing of rewarding and aversive taste stimuli.
title_fullStr Effects of pramipexole on the processing of rewarding and aversive taste stimuli.
title_full_unstemmed Effects of pramipexole on the processing of rewarding and aversive taste stimuli.
title_short Effects of pramipexole on the processing of rewarding and aversive taste stimuli.
title_sort effects of pramipexole on the processing of rewarding and aversive taste stimuli
work_keys_str_mv AT mccabec effectsofpramipexoleontheprocessingofrewardingandaversivetastestimuli
AT harwoodj effectsofpramipexoleontheprocessingofrewardingandaversivetastestimuli
AT brouwers effectsofpramipexoleontheprocessingofrewardingandaversivetastestimuli
AT harmerc effectsofpramipexoleontheprocessingofrewardingandaversivetastestimuli
AT cowenp effectsofpramipexoleontheprocessingofrewardingandaversivetastestimuli